Alexander I. Spira, Alexander E. Drilon, Jonathan W. Goldman, Narjust Florez, Petros Christopoulos, Maurice Pérol, Dih-Yih Chen, Feiwu Ran, Xianyu Zhang, Geoffrey Liu, Caicun Zhou. "Randomized, double-blind, phase 3 TRUST-IV study of adjuvant taletrectinib vs placebo in patients with stage IB–IIIA ROS1+ non-small cell lung cancer (NSCLC).." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.tps8130